Learn More
Medchemexpress LLC DNQX (FG 9041) | 2379-57-9 | C8H4N4O6 | 200 MG

Supplier: Medchemexpress LLC HY15067200MG
DNQX (FG 9041) is a quinoxaline derivative and a selective, potent competitive non-NMDA glutamate receptor antagonist. It is characterized by its activity against various glutamate receptors.
- Selective, potent competitive non-NMDA glutamate receptor antagonist
- Targets AMPA receptors with an IC50 of 0.5 μM
- Targets kainate receptors with an IC50 of 2 μM
- Targets NMDA receptors with an IC50 of 40 μM
- Selectively depolarizes thalamic reticular nucleus (TRN) neurons in vitro
- Diminishes phencyclidine (PCP) induced hsp70 induction in vivo
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.